Literature DB >> 233696

Ectopic production of high molecular weight calcitonin and corticotropin by human small cell carcinoma cells in tissue culture: evidence for separate precursors.

X Y Bertagna, W E Nicholson, O S Pettengill, G D Sorenson, C D Mount, D N Orth.   

Abstract

The DMS-79 continuous line of human small cell lung carcinoma cells, which produces immunoreactive (IR)-corticotropin (ACTH), -lipotropin (LPH), and -beta-endorphin (beta END), was found to produce IR-calcitonin (CT). Two major high molecular weight (HMW) forms of IR-CT were observed after gel exclusion chromatography under denaturing conditions (mol wt. approximately 7,000 and approximately 14,000), as well as a minor HMW IR-CT component (mol. wt. approximately 70,000). None of these IR-CT materials was extracted from DMS-79 medium by affinity chromatography using an ACTH antibody covalently bound to agarose. These results demonstrate ectopic production of HMW forms of CT and ACTH/LPH/beta END by human lung tumor cells in tissue culture, but do not support the existence of a common CT/ACTH/LPH/beta END precursor molecule.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 233696     DOI: 10.1210/jcem-47-6-1390

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  Establishment and characterization of a cell line (IGSK-3) secreting human chorionic gonadotropin, adrenocorticotropic hormone and parathyroid hormone-related protein derived from primary poorly differentiated adenocarcinoma of the stomach.

Authors:  Shigeo Yamashita; Naoto Takahashi; Hisashi Hashimoto; Toshiaki Tachibana; Taka Nakahara; Akihiro Ohyama; Katsuhiko Yanaga
Journal:  Hum Cell       Date:  2008-08       Impact factor: 4.174

2.  Purification and partial characterization of high-molecular-weight forms of ectopic calcitonin from a human bronchial carcinoma cell line.

Authors:  J Lumsden; J Ham; M L Ellison
Journal:  Biochem J       Date:  1980-10-01       Impact factor: 3.857

3.  The importance of determining procalcitonin and C reactive protein in different stages of sepsis.

Authors:  Zana Baruti Gafurri; Hidajet Pacarizi; Bukurije Zhubi; Luljeta Begolli; Valdete Topciu
Journal:  Bosn J Basic Med Sci       Date:  2010-02       Impact factor: 3.363

4.  Distribution of beta-endorphin immunoreactivity in normal human pituitary.

Authors:  G Mendelsohn; R D'Agostino; J C Eggleston; S B Baylin
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

5.  Immunoreactive calcitonin in brain regions and pituitary of sheep.

Authors:  S Balabanova; O King; R Nowak; H Sachs; D Leupold
Journal:  J Endocrinol Invest       Date:  1985-10       Impact factor: 4.256

6.  Tumour calcitonin. Interaction with specific calcitonin receptors.

Authors:  J Ham; M L Ellison; J Lumsden
Journal:  Biochem J       Date:  1980-09-15       Impact factor: 3.857

7.  Immunohistochemical study of pheochromocytomas. An investigation of methionine-enkephalin, vasoactive intestinal peptide, somatostatin, corticotropin, beta-endorphin, and calcitonin in 16 tumors.

Authors:  J Hassoun; G Monges; P Giraud; J F Henry; C Charpin; H Payan; M Toga
Journal:  Am J Pathol       Date:  1984-01       Impact factor: 4.307

8.  Immunohistochemical and immunoelectron-microscopic study of pituitary adenomas associated with Cushing's disease. A report of 13 cases.

Authors:  C Charpin; J Hassoun; C Oliver; P Jaquet; B Argemi; F Grisoli; M Toga
Journal:  Am J Pathol       Date:  1982-10       Impact factor: 4.307

9.  Adrenocorticotropin, calcitonin, and antidiuretic hormone as tumor markers in patients with bronchogenic carcinoma of various histological types.

Authors:  W Winkelmann; U Deuss; B Allolio; W Hummerich; D Kaulen; H Brosch; A Guyot; C Arnold
Journal:  Klin Wochenschr       Date:  1984-11-02

10.  Discriminative power of inflammatory markers for prediction of tumor necrosis factor-alpha and interleukin-6 in ICU patients with systemic inflammatory response syndrome (SIRS) or sepsis at arbitrary time points.

Authors:  M Oberhoffer; S Russwurm; D Bredle; K Chatzinicolaou; K Reinhart
Journal:  Intensive Care Med       Date:  2000-03       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.